Literature DB >> 861375

Prognostic classification of Hodgkin disease in pathologic stage III, based on anatomic considerations.

R K Desser, H M Golomb, J E Ultmann, D J Ferguson, E M Moran, M L Griem, J Vardiman, B Miller, N Oetzel, D Sweet, E P Lester, J J Kinzie, R Blough.   

Abstract

Fifty-two patients with pathologic stage III Hodgkin disease were studied in an effort to determine whether location of involved abdominal nodes influenced survival. Treatment consisted of total nodal radiotherapy with or without subsequent combination chemotherapy. Th initial radiation field was the "extended mantle," which included supradiaphragmatic nodes, the splenic hilar area, and paraaortic nodes to the level of L2-L4. Subsequently, lower paraaortic and iliac regions were treated ("lower inverted Y"). Patients with disease limited to the spleen and/or splenic, celiac, or portal nodes ("anatomic substage" III1) had a more favorable 5-yr survival than did patients with involvement of paraaortic, iliac, or mesenteric nodes ("anatomic substage" III2): 93% versus 57%, respectively (p less than 0.05). The addition of combination chemotherapy to total nodal irradiation was associated with improved survival of patients in stage III2, but not of those in stage III1.

Entities:  

Mesh:

Year:  1977        PMID: 861375

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

Review 1.  [Hodgkin's disease. Results in diagnosis and treatment (author's transl)].

Authors:  D Huhn; W Wilmanns
Journal:  Klin Wochenschr       Date:  1979-04-17

2.  Radiation therapy alone versus radiation therapy and chemotherapy in the management of Hodgkin's disease.

Authors:  L D Glenn; P P Kumar
Journal:  J Natl Med Assoc       Date:  1990-02       Impact factor: 1.798

3.  [The role of radiotherapy and chemotherapy in the treatment of lymphomas].

Authors:  B Ramot; I Ben-Bassat
Journal:  Bull World Health Organ       Date:  1980       Impact factor: 9.408

4.  [Laparotomy in Hodgkin's disease: significance of splenic involvement].

Authors:  E Tawil; J P Mercier
Journal:  Can Med Assoc J       Date:  1984-07-15       Impact factor: 8.262

5.  Changing priorities in Hodgkin's disease.

Authors:  C J Williams
Journal:  Br Med J       Date:  1980-05-31

Review 6.  Chemotherapy, radiotherapy and combined modality for Hodgkin's disease, with emphasis on second cancer risk.

Authors:  J G Franklin; M D Paus; A Pluetschow; L Specht
Journal:  Cochrane Database Syst Rev       Date:  2005-10-19

7.  Response-dependent and reduced treatment in lower risk Hodgkin lymphoma in children and adolescents, results of P9426: a report from the Children's Oncology Group.

Authors:  Cameron K Tebbi; Nancy P Mendenhall; Wendy B London; Jonathan L Williams; Robert E Hutchison; Thomas J Fitzgerald; Pedro A de Alarcón; Cindy Schwartz; Allen Chauvenet
Journal:  Pediatr Blood Cancer       Date:  2012-08-21       Impact factor: 3.167

8.  [Diagnostic value of clinical methods in the staging of abdominal Hodgkin's disease (author's transl)].

Authors:  S L Roth; H Dombrowski; W D Gassel; F Hess; K Joseph; D Maroske; K P Riester; P Schmitz-Moormann; W B Schwerk; K Havemann
Journal:  Blut       Date:  1980-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.